Kansas Statutes > Chapter 65 > Article 6b – Amygdalin (Laetrile)


§ 65-6b01	Amygdalin (laetrile); definitions
§ 65-6b02	Same; use in treatment by physician, limitations on interference with
§ 65-6b03	Same; when prescribed or administered
§ 65-6b04	Same; act not endorsement; certain treatment by physician not prohibited
§ 65-6b05	Same; written informed request
§ 65-6b06	Amygdalin (laetrile); registration to manufacture; duties of secretary of health and environment; fees
§ 65-6b07	Same; permit to distribute at wholesale; duties of secretary of health and environment; fees; hearing
§ 65-6b08	Same; penalty for violations of act
§ 65-6b09	Same; permit to sell, offer for sale or distribute to public; duties of secretary of health and environment; fees; hearing
§ 65-6b10	Same; amygdalin (laetrile) enforcement fee fund
§ 65-6b11	Same; records required
§ 65-6b12	Same; act not applicable to certain persons

Appropriation: The provision of funds, through an annual appropriations act or a permanent law, for federal agencies to make payments out of the Treasury for specified purposes. The formal federal spending process consists of two sequential steps: authorization
Health care facility: means a facility other than a medical care facility providing care for persons who are ill or infirm and includes adult care homes as such term is defined by Kan. See Kansas Statutes 65-6b01
Medical care facility: means the same as the meaning ascribed thereto in Kan. See Kansas Statutes 65-6b01
Physician: means a person licensed to practice medicine and surgery by the state board of healing arts. See Kansas Statutes 65-6b01
State: when applied to the different parts of the United States, includes the District of Columbia and the territories. See Kansas Statutes 77-201
Written informed request: means the request for the prescription of amygdalin (laetrile) and the form for such request established under Kan. See Kansas Statutes 65-6b01